Exelixis Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
32.38
-1.75
(-5.13%)
Volume:
3,626,869
52 week range:
20.02 - 37.59
Market Cap:
9.747B
Company Description:
Exelixis, Inc. focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. Its products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma.